Jerome Combes Knoke
About Jerome Combes Knoke
Jerome Combes Knoke serves as the Senior Vice President of Corporate Development & Strategy at Insightful Science and Dotmatics. He has extensive experience in corporate development, investment banking, and strategy across various industries, including life sciences and financial services.
Current Role at Dotmatics
Jerome Combes Knoke serves as the Senior Vice President of Corporate Development & Strategy at Dotmatics, a position he has held since 2021. In this role, he is responsible for overseeing corporate development initiatives and strategic planning. His tenure at Dotmatics has been marked by a focus on enhancing the company's strategic positioning within the life sciences sector.
Previous Experience at Standex International
Prior to his current role, Knoke worked at Standex International as the Director of Strategy & Corporate Development from 2018 to 2021. During his three years in this position, he played a significant role in the portfolio transformation of the company, which involved $350 million in acquisitions and divestitures. His work contributed to the strategic growth of Standex.
Educational Background
Jerome Combes Knoke has a solid educational foundation. He studied at Carnegie Mellon University, where he earned a Bachelor of Science (BSc) in Economics and Computational Finance, graduating in 2009. He furthered his education at Columbia Business School, achieving a Master of Business Administration (M.B.A.) in 2015. His academic background supports his expertise in corporate development and strategy.
Career Path and Industry Experience
Knoke has extensive industry experience in life sciences, financial services, and industrial technology. His career includes roles at notable firms such as the Boston Consulting Group, where he worked as a Consultant focusing on growth strategy and corporate development from 2014 to 2017. He also held positions at Keefe, Bruyette & Woods and Kythera Capital Management LLC, where he gained valuable insights into investment banking and private equity.
Significant Contributions and Achievements
Throughout his career, Knoke has been involved in several high-profile transactions. He participated in the GSK/Novartis asset swap, valued at $5.3 billion, and contributed to the IPO of First Republic Bank, which raised $300 million. Additionally, he played a key role in the acquisition of Biolegend, a transaction valued at $5.25 billion, highlighting his impact in corporate development.